PCDHGA10: A Non-Code RNA Molecule as A Potential Drug Target and Biomarker

Target Name: PCDHGA10

NCBI ID: G56106

PCDHGA10

PCDHGA10: A Non-Code RNA Molecule as A Potential Drug Target and Biomarker

PCDHGA10 (Peripheral Component Data High-Aggregate (HAG) 10) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of the hematopoietic stem cell (HSC) proliferation and has been shown to play a role in the development and progression of various diseases, including cancer.

The PCDHGA10 gene

The PCDHGA10 gene is located on chromosome 19 and encodes a non-coding RNA molecule of approximately 200 amino acids. The RNA molecule is composed of seven exons, which are transcribed from the gene's DNA. The first exon encodes a 5'-untranslated region ( UTR) that is typically excluded from translations, while the second exon encodes a 5'-UTR that is involved in the formation of a stem-loop structure. The remaining exons encode the amino acids that make up the protein.

The PCDHGA10 gene

The PCDHGA10 gene is a member of the Peripheral Component Data (PCD) gene family, which is characterized by the presence of a PCD domain in the protein encoded by the gene. The PCD domain is a conserved region that is found in various proteins and is involved in the formation of stem-loop structures. The PCDHGA10 gene is unique in that it encodes a non-coding RNA molecule that has been shown to play a role in the regulation of hematopoietic stem cell (HSC) proliferation.

The PCDHGA10 protein

The PCDHGA10 protein is a key regulator of HSC proliferation. It has been shown to play a role in the maintenance of stem cells in the bone marrow and in the development of various diseases, including cancer. The PCDHGA10 protein is produced from the PCDHGA10 gene and is expressed in a variety of tissues and cells, including blood cells, tissues, and organs.

The PCDHGA10 protein is involved in the regulation of DNA replication and cell cycle progression. It has been shown to interact with the protein kinase B-complex, which is involved in the regulation of DNA replication and cell cycle progression. in the regulation of cell adhesion and has been shown to play a role in the development and maintenance of various tissues and organs.

The PCDHGA10 protein is also involved in the regulation of inflammation and has been shown to play a role in the development of various diseases, including cancer. It has been shown to interact with the transcription factor NF-kappa-B and has been shown to play a role in the regulation of inflammation and pain.

The PCDHGA10 gene and its function

The PCDHGA10 gene is involved in the regulation of various cellular processes and has been shown to play a role in the development and progression of various diseases. Its function is closely related to the regulation of hematopoietic stem cell (HSC) proliferation and the maintenance of stem cells in the bone marrow.

The PCDHGA10 gene is a potential drug target and biomarker due to its involvement in the regulation of HSC proliferation and its potential role in the development and progression of various diseases. Further research is needed to fully understand the role of the PCDHGA10 gene in the regulation of HSC proliferation and its potential as a drug target and biomarker.

Conclusion

PCDHGA10 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. Its function is closely related to the regulation of hematopoietic stem cell (HSC) proliferation and its potential role in the development and progression of various diseases. Further research is needed to fully understand the role of the PCDHGA10 gene in the regulation of HSC proliferation and its potential as a drug target and biomarker.

Protein Name: Protocadherin Gamma Subfamily A, 10

Functions: Potential calcium-dependent cell-adhesion protein. May be involved in the establishment and maintenance of specific neuronal connections in the brain

The "PCDHGA10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PCDHGA10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets